5 / 8
Page 30
Parkinson’s & Movement Disorders
November 11-12, 2019 | London, UK
7
th
International Conference on
Parkinson’s 2019
November 11-12, 2019
J Neurol Clin Neurosci . | Volume 3
Volume 3
Journal of Neurology and Clinical Neuroscience
Quality of life in patients with Parkinson’s disease assessed in a University Hospital in
Bogotá, Colombia
González Aura Virginia
Montreal Neurological Institute, Colombia
P
arkinson’s disease is the second most frequent neurodegenerative disease, and its incidence and prevalence
increase with age. Although the treatment can improve patient’s symptoms and quality of life, this disease
continues to generate progressive disability. Objective: To describe the performance of quality of life in the context
of socio-demographic and clinical factors through MDS UPDRS, Hoehn and Yahr and PDQ-39, in patients with
Parkinson’s disease treated at San José Hospital, Bogotá, Colombia. Patients and methods: Scales were administered
to patients with a diagnosis of Parkin- son’s disease. Socio-demographic data and some important clinical variables
were collected. Socio-demographic and clinical characteristics were correlated with PDQ 39; the Hoehn and Yahr
Scale with the MDS UPDRS and the PDQ-39; and finally, the MDS UPDRS Scale with the PDQ-39. Results: The
characteristics associated with the worst scores in the PDQ-39 Scale are the need for a caregiver, longer time of disease
progression, and high scores in parts i and ii of the MDS UPDRS scale. Conclusions: There are socio-demographic
and clinical factors that are involved in the deterioration of patients’ quality of life. Drug treatment must be adjusted in
such a way that patient’s independence and the ability to carry out all the activities of daily life are taken into account,
while continuing searching for non-motor symptoms for adequate management.
avgonzalez@fucsalud.edu.co